Back to mobile site

Sarissa Capital held talks with Amarin Corp. (AMRN) on ways to maximize value

June 3, 2022 9:29 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Sarissa Capital held talks with Amarin Corp. (NASDAQ: AMRN) on ways to maximize value - 13D.

From the filing:

The Reporting Persons have had discussions with the Issuer and other interested parties about ways to maximize the value of the Issuer’s assets. More recently, the Reporting Persons discussed with the Issuer the disappointing first quarter results. The Reporting Persons believe that the meaningful decrease in Share price following the earnings announcement reflects the Issuer’s insufficient adjustment to changing market conditions for its key drug Vascepa and investor concerns about the ability of leadership as currently constituted to navigate the Issuer during this critical time. The Reporting Persons believe that the expertise and experience of its principals would be extremely beneficial to the Issuer and intend to seek representation on the Issuer’s board of directors. The Reporting Persons believe the Shares continue to be significantly undervalued.
The Reporting Persons thank the many shareholders who have reached out to them seeking guidance on how to vote at the Issuer’s upcoming annual meeting. The Reporting Persons will disclose their intentions with respect to the Issuer’s upcoming annual meeting, including how they intend to vote their shares, following the outcome of the ongoing discussions with the Issuer. The Reporting Persons will continue to review their investment on an ongoing basis and reserve the right to, from time to time and at any time: (i) acquire additional Securities of the Issuer in the open market or otherwise; (ii) dispose of any or all of their Securities in the open market or otherwise; or (iii) engage in any hedging or similar transactions with respect to the Securities.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

13Ds, Hedge Funds

Related Entities

13D, Earnings, Definitive Agreement